financetom
Business
financetom
/
Business
/
Taco Bell parent Yum Brands sales fall as weak US demand lingers
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Taco Bell parent Yum Brands sales fall as weak US demand lingers
Aug 6, 2024 4:55 AM

(Reuters) - Yum Brands ( YUM ) reported a bigger-than-expected fall in same-store sales for the second quarter as sticky inflation discouraged lower-income Americans from spending on dining out.

Like its peers in the fast-food industry, the Taco Bell parent has been investing in loyalty programs and refreshing its menus in an attempt to appeal to budget-conscious consumers.

However, stiff competition for value meals and promotions has dogged Yum's KFC ( YUM ) business in the United States this year, with consumers increasingly preferring to cook more affordable meals at home.

Same-store sales at the company's KFC ( YUM ) division fell 5% in the United States in the second quarter, compared with a 7% decline in the prior quarter.

Weakness in sales this quarter at Yum echoes results from other restaurant majors such as Domino's, McDonald's and Starbucks.

Fast-food companies were engaged in a "value war" this quarter, offering some popular items at a discount in a bid to offset steep menu-price rises in the U.S. over the last two years.

The consumer price index for food away from home increased 4.1% between June 2023 and June 2024, up from 4% growth in May, according to data from the National Restaurant Association.

Fresh menu items such as the Cantina Chicken and the popular Taco Tuesday promotional event helped drive growth in comparable sales at Yum's key Taco Bell division to 5%, ahead of expectations of 3.6%, according to LSEG data.

This helped Yum narrow its quarterly overall same-store sales decline to 1%, from 3% in the preceding quarter. However, this was wider than market expectations for a decline of 0.2%.

Excluding items, Yum Brands ( YUM ) reported a profit of $1.35 per share for the quarter ended June 30, edging past estimates of $1.33. (This story has been corrected to remove the reference to CEO's comment in paragraph 8)

(Reporting by Juveria Tabassum; Editing by Devika Syamnath)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved